CORAR Foresees No Imminent Risk to Molybdenum-99 (Mo-99) Supply

​

The Council on Radionuclides and Radiopharmaceuticals (CORAR), a Washington, DC based trade association, believes that the risk of a substantial shortage of molybdenum-99 (Mo-99) in the next five years is overstated in a September 12, 2016 report from the National Academies of Sciences, Engineering, and Medicine (the Academies). Mo-99 is the parent isotope of technetium-99m (Tc 99m) which is used in 30 to 40 million nuclear medicine procedures worldwide every year.

Currently, Mo-99 producers do not report any shortages and have taken significant steps to continue providing reliable supply of Mo-99 after Canadian suppliers cease routine production after October 31, 2016. 

Although it is impossible to totally eliminate the risk of Mo-99 shortages over the next five years, CORAR believes the risk is mitigated by the significant industry steps mentioned above. Given that the Academies’ report has been released as a prepublication copy, CORAR will encourage the Academies to reevaluate the available data and consider amending its report to more accurately represent the risk of severe Mo-99 shortages between 2016 and 2021.

To read more please visit http://www.businesswire.com/news/home/20161020006576/en/

Source: BUSINESS WIRE